Europlasma: terminates its bond financing contract – 05/10/2022 at 10:05


(CercleFinance.com) – Europlasma announces that after discussions between Global Corporate Finance Opportunities 11 (‘GCFO 11’), the Board of Directors has decided to terminate the financing contract by issuing bonds convertible into shares with warrants of attached shares (‘OCABSA’) concluded between Europlasma and GCFO 11 on April 16, 2021.

The Group favors debt financing for the future, allowing it to continue to deploy its turnaround strategy without the dilutive impact for shareholders resulting from the bond financing agreement that existed until then.

However, this turnaround would not have been possible without the European High Growth Opportunities and GCFO11 funds, which were able to support the recovery when the Group could not benefit from traditional financing.

As of today, no more instrument related to this contract can be issued, the OCABSA in circulation continuing to benefit from the provisions provided for in the existing bond financing contract.



Source link -86